Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGN475 in osteoarthritis of the knee
NCT00944892Phase 2Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Aug 2009
- Primary completion
- May 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of fasinumab in knee osteoarthritis (OA), sponsored by Regeneron Pharmaceuticals. Started Aug 2009; status: completed.
02
Drugs
fasinumab
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00944892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944892.